PetMed Express, Inc.
PETS
$3.40
-$0.09-2.58%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 44.36M | 51.18M | 46.47M | 52.98M | 58.04M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 44.36M | 51.18M | 46.47M | 52.98M | 58.04M |
| Cost of Revenue | 31.95M | 36.78M | 27.52M | 38.08M | 39.27M |
| Gross Profit | 12.42M | 14.40M | 18.95M | 14.91M | 18.77M |
| SG&A Expenses | 17.29M | 18.90M | 30.83M | 13.77M | 16.26M |
| Depreciation & Amortization | 2.28M | 2.28M | 2.07M | 1.59M | 1.66M |
| Other Operating Expenses | -- | -- | -1.18M | -- | -- |
| Total Operating Expenses | 51.52M | 57.96M | 59.25M | 53.43M | 57.18M |
| Operating Income | -7.16M | -6.78M | -12.78M | -450.00K | 860.00K |
| Income Before Tax | -8.51M | -34.14M | -5.98M | -242.00K | 925.00K |
| Income Tax Expenses | 9.00K | 9.00K | 5.66M | 465.00K | -1.40M |
| Earnings from Continuing Operations | -8.52M | -34.15M | -11.64M | -707.00K | 2.33M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.52M | -34.15M | -11.64M | -707.00K | 2.33M |
| EBIT | -7.16M | -6.78M | -12.78M | -450.00K | 860.00K |
| EBITDA | -4.88M | -4.50M | -10.71M | 1.14M | 2.52M |
| EPS Basic | -0.41 | -1.65 | -0.56 | -0.03 | 0.11 |
| Normalized Basic EPS | -0.22 | -0.20 | -0.39 | -0.01 | 0.04 |
| EPS Diluted | -0.41 | -1.65 | -0.56 | -0.03 | 0.11 |
| Normalized Diluted EPS | -0.22 | -0.20 | -0.39 | -0.01 | 0.04 |
| Average Basic Shares Outstanding | 20.89M | 20.76M | 20.64M | 20.63M | 20.60M |
| Average Diluted Shares Outstanding | 20.89M | 20.76M | 20.64M | 20.63M | 20.94M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.26% | 0.00% | -0.04% | -0.14% | 3.05% |